Home
About
FAQ
History (4)
Cost effectiveness of biologic therapies for plaque psoriasis.
Finite Element Based Pelvic Injury Metric Creation and Validation in Lateral Impact for a Human Body Model.
On and off the horse: mechanisms and patterns of injury in mounted and unmounted equestrians.
Tildrakizumab: A Review of Phase II and III Clinical Trials.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost effectiveness of biologic therapies for plaque psoriasis.
Ahn CS, Gustafson CJ, Sandoval LF, Davis SA, Feldman SR. Cost effectiveness of biologic therapies for plaque psoriasis. Am J Clin Dermatol. 2013 Aug; 14(4):315-26.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Biological Therapy
Cost of Illness
Cost-Benefit Analysis
Female
Health Care Costs
Humans
Immunoglobulin G
Male
Middle Aged
Psoriasis
Quality of Life
Receptors, Tumor Necrosis Factor
Recombinant Fusion Proteins
Treatment Outcome
United States
authors with profiles
Steven R. Feldman MD, PhD
Christine Ahn MD